Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 875

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 875
---
134 |
| Total accrued expenses and other current liabilities |     | $              | 2,361 |     | $    | 2,211 |

| 5. | Notes Payable |

Notes payable outstanding consisted of the following as of the periods presented:

|                                       |     | December 31, 2024 |     |     |            |     |     | December 31, 2023 |     |     |            |     |
|:--------------------------------------|:----|:------------------|----:|:----|:-----------|----:|:----|:------------------|----:|:----|:-----------|----:|
|                                       |     | Principal         |     |     | Fair Value |     |     | Principal         |     |     | Fair Value |     |
|                                       |     | -in thousands     |     |     |            |     |     |                   |     |     |            |     |
| Notes payable:                        |     |                   |     |     |            |     |     |                   |     |     |            |     |
| 2020 notes                            |     | $                 | 250 |     | $          | 250 |     | $                 | 250 |     | $          | 241 |
| Other notes payable                   |     |                   | 379 |     |            | 379 |     |                   | 379 |     |            | 379 |
| Small Business Administration loan    |     |                   |   — |     |            |   — |     |                   | 150 |     |            | 150 |
| Total notes payable                   |     | $                 | 629 |     |            | 629 |     | $                 | 779 |     |            | 770 |
| Less: current portion                 |     |                   |     |     |            | 629 |     |                   |     |     |            | 620 |
| Notes payable, net of current portion |     |                   |     |     | $          |   — |     |                   |     |     | $          | 150 |

The Company elected the fair value option for the 2020 notes (see Note 3). The other notes payable approximate their fair value because interest rates are at prevailing market rates. 2020 Notes In October 2020, the Company refinanced certain notes payable (the “2020 notes”), with an aggregate principal amount of $3.0 million with